NATRNATURES SUNSHINE PRODUCTS INC(NATR)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 275053NATR stock profile & AI dashboard →

13F Pro Quality Score

55.7/100

Rank #1,144 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

45.6/100

Profitability

58.3/100

Balance Sheet

81.4/100

Earnings Quality

86.3/100

Free Cash Flow

46.0/100

Institutional Flow

69.2/100

Revenue Scale

36.1/100

Dilution Risk

52.4/100

NATR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NATURES SUNSHINE PRODUCTS INC (NATR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NATR at 55.7/100 on a 32-signal composite quality model, placing it at rank #1,144 of 2,879 stocks — the top half of the AI-ranked universe. NATR scores in the top quartile across earnings quality (86.3), balance sheet strength (81.4). Areas of concern include revenue scale (36.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), NATURES SUNSHINE PRODUCTS INC reports quarterly revenue of $122.9M, net income of $5.1M, an operating margin of 7.8%. Top institutional holders of NATR by reported 13-F value include WYNNEFIELD CAPITAL, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., BlackRock,, based on the most recent SEC filings. NATR trades on the Nasdaq exchange and files with the SEC under CIK 275053. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NATR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATURES SUNSHINE PRODUCTS INC directly from SEC EDGAR. NATURES SUNSHINE PRODUCTS INC's 13F Pro composite quality score has ranged between 44 and 56 since 2024, currently 55.7 — an improving long-term trajectory across 15 quarterly and live scoring snapshots.

Revenue

Q1 2026

$122.9M

Net Income

Q1 2026

$5.1M

Free Cash Flow

Q1 2026

$-4.3M

Operating Margin

Q1 2026

7.8%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+5.7% YoY
$480.1MFY 2025
FY22 $421.9MFY23 $445.3MFY24 $454.4MFY25 $480.1M

Net Income

+153.7% YoY
$19.5MFY 2025
FY22 $-390.0KFY23 $15.1MFY24 $7.7MFY25 $19.5M

Operating Income

+23.1% YoY
$24.7MFY 2025
FY22 $16.3MFY23 $18.7MFY24 $20.1MFY25 $24.7M

EPS (Diluted)

+165.0% YoY
$1.06FY 2025
FY22 $-0.02FY23 $0.77FY24 $0.40FY25 $1.06

Total Assets

+8.4% YoY
$261.1MFY 2025
FY22 $229.8MFY23 $249.8MFY24 $240.9MFY25 $261.1M

Total Debt

FY 2025
FY22 $3.5MFY23 $0.00FY24 FY25

Op. Cash Flow

+39.6% YoY
$35.3MFY 2025
FY22 $710.0KFY23 $41.2MFY24 $25.3MFY25 $35.3M

AI Insight: NATR Financial Trends

Revenue growth accelerated to 9% year-over-year in Q3 2025 but operating cash flow turned negative in Q1 2026.

Revenue increased from $111M in Q2 2024 to $123M in Q1 2026, with strongest growth in Q3 2025 at $128M.

Net income stabilized around $4-5M across recent quarters after breakeven performance in Q4 2024.

Operating income doubled from $5M in Q4 2025 to $10M in Q1 2026.

Operating cash flow swung from positive $10M in Q4 2025 to negative $2M in Q1 2026.

Revenue declined sequentially from Q3 2025 peak of $128M to $123M in Q1 2026.

AI Insight: NATR Ratio Trends

Operating margin surged to 7.8% in Q1 2026, the highest level in the observed period, while profitability remains volatile quarter-to-quarter.

Operating margin jumped from 4.3% in Q4 2025 to 7.8% in Q1 2026, marking significant sequential improvement.

Net profit margin stabilized around 4.2% in Q1 2026, consistent with Q3 2025 and Q1 2025 levels.

ROA recovered to 7.8% in Q1 2026 after dipping to 6.3% in Q4 2025.

Operating margins show high volatility, swinging from 3.7% to 7.8% across recent quarters without clear trend.

Company posted negative net profit margin of -0.3% in Q4 2024, indicating potential earnings instability.

Get alerted when NATR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NATURES SUNSHINE PRODUCTS INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put NATR on your watchlist

Track score changes the day NATURES SUNSHINE PRODUCTS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is NATR a good stock to buy?

13F Pro's AI-powered analysis of NATURES SUNSHINE PRODUCTS INC (NATR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NATR are available on the NATR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NATR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NATR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATURES SUNSHINE PRODUCTS INC's investment landscape.